Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter A Tauber

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Reviews. Immunology|March 26, 2026
T cell lymphomas: cancers of aberrant immune synapse signallingPeter A Tauber, Jürgen Ruland
Immunology Letters|March 22, 2017
Pharmacological targeting of allergen-specific T lymphocytesPeter A Tauber, Winfried F Pickl
Immunology Letters|June 11, 2019
The making and function of CAR cellsMaja Zabel, Peter A Tauber, Winfried F Pickl
International Archives of Allergy and Immunology|December 12, 2023
The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024Al Nasar Ahmed Sehgal, Peter A Tauber, Robert B Stieger, et al.
International Journal of Molecular Sciences|July 12, 2025
Moloney Murine Leukemia Virus-like Nanoparticles Pseudo-Typed with SARS-CoV-2 RBD for Vaccination Against COVID-19Bernhard Kratzer, Pia Gattinger, Peter A Tauber, et al.
Frontiers in Immunology|April 24, 2023
The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4<sup>+</sup> T cells resembling iTregPeter A Tauber, Bernhard Kratzer, Philipp Schatzlmaier, et al.
Nature Immunology|June 24, 2020
Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunityUrsula Smole, Naina Gour, Jordan Phelan, et al.
Allergy|July 14, 2024
Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19Bernhard Kratzer, Pia Gattinger, Doris Trapin, et al.
Frontiers in Immunology|October 17, 2025
Severe COVID-19 induces prolonged elevation of the acute-phase protein pentraxin 3Bernhard Kratzer, Robert B Stieger, Seyma Durmus, et al.
Allergy|October 31, 2020
Immunological imprint of COVID-19 on human peripheral blood leukocyte populationsBernhard Kratzer, Doris Trapin, Paul Ettel, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Reviews. Immunology|March 26, 2026
T cell lymphomas: cancers of aberrant immune synapse signallingPeter A Tauber, Jürgen Ruland
Immunology Letters|March 22, 2017
Pharmacological targeting of allergen-specific T lymphocytesPeter A Tauber, Winfried F Pickl
Immunology Letters|June 11, 2019
The making and function of CAR cellsMaja Zabel, Peter A Tauber, Winfried F Pickl
International Archives of Allergy and Immunology|December 12, 2023
The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024Al Nasar Ahmed Sehgal, Peter A Tauber, Robert B Stieger, et al.
International Journal of Molecular Sciences|July 12, 2025
Moloney Murine Leukemia Virus-like Nanoparticles Pseudo-Typed with SARS-CoV-2 RBD for Vaccination Against COVID-19Bernhard Kratzer, Pia Gattinger, Peter A Tauber, et al.
Frontiers in Immunology|April 24, 2023
The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4<sup>+</sup> T cells resembling iTregPeter A Tauber, Bernhard Kratzer, Philipp Schatzlmaier, et al.
Nature Immunology|June 24, 2020
Serum amyloid A is a soluble pattern recognition receptor that drives type 2 immunityUrsula Smole, Naina Gour, Jordan Phelan, et al.
Allergy|July 14, 2024
Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19Bernhard Kratzer, Pia Gattinger, Doris Trapin, et al.
Frontiers in Immunology|October 17, 2025
Severe COVID-19 induces prolonged elevation of the acute-phase protein pentraxin 3Bernhard Kratzer, Robert B Stieger, Seyma Durmus, et al.
Allergy|October 31, 2020
Immunological imprint of COVID-19 on human peripheral blood leukocyte populationsBernhard Kratzer, Doris Trapin, Paul Ettel, et al.
Pageof 2